Navigation Links
Bisexuality not a transitional phase among women, according to new research
Date:1/15/2008

WASHINGTON -- Bisexuality in women appears to be a distinctive sexual orientation and not an experimental or transitional stage that some women adopt "on their way" to lesbianism, according to new research published by the American Psychological Association.

The study of 79 non-heterosexual women over 10 years found that bisexual women maintained a stable pattern of attraction to both sexes. In addition, the research appears to have debunked the stereotype that bisexual women are uninterested in or unable to commit to long-term monogamous relationships.

"This research provides the first empirical examination of competing assumptions about the nature of bisexuality, both as a sexual identity label and as a pattern of nonexclusive sexual attraction and behavior," wrote University of Utah psychologist Lisa M. Diamond, PhD, who conducted the study. "The findings demonstrate considerable fluidity in bisexual, unlabeled and lesbian women's attractions, behaviors and identities and contribute to researchers' understanding of the complexity of sexual-minority development over the life span."

Results of the research were published in the January issue of Developmental Psychology, published by the APA. This special issue of the journal focuses on research into psychological topics concerning sexual orientation and gender identity.

Diamond used interview data collected five times over a decade from 79 women who identified as lesbian, bisexual or unlabeled. The subjects initially ranged in age from 18 to 25 years old.

Among Diamond's findings:

  • Bisexual and unlabeled women were more likely than lesbians to change their identity over the course of the study, but they tended to switch between bisexual and unlabeled rather than to settle on lesbian or heterosexual as their identities.

  • Seventeen percent of respondents switched from a bisexual or unlabeled identity to heterosexual during the study
    '/>"/>

Contact: Pam Willenz
pwillenz@apa.org
202-336-5707
American Psychological Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Seabrook House Opens Transitional Living Facility: Seabrook West
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma
4. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
5. Cytopia Commences Phase II Cancer Drug Study
6. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
7. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
8. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
9. Early Phase II results show bosutinib safe, effective for CML
10. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
11. VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...NYSE: CNC ) today announced that it will present ...xt few weeks. ,, Next week, at the Credit Suisse 1...mber 11-13, 2009, at the Arizona Biltmore Resort a... November 11th at 4:30 p.m. Mountain Time. Investo...,s presentation at: http://w.on24.com/r.htm?e=17...
(Date:11/6/2009)...of Veterans Affairs held a historic three-day conf...ning of a new mission for the agency - to end vete... VA clinicians and health care specialists, repres...g support for homeless and low-income veterans, an...resented by the National Coalition for Homeless Ve...
(Date:11/6/2009)...ands of Idahoans Struggling with High Rx Costs, Me...BOISE, Idaho, Nov. 6 As the debate over health ...readies to vote on critical health care reform leg...daho,s U.S. Representatives to support the bill. ... Act (H.R. 3962), which will close the Medicare pr...
(Date:11/6/2009)... (NYSE: HSP ), a leading global specialty pharmac...ounced that the company will present at the Piper ...esday, Dec. 2, 2009 in New York City. ,, The prese... time on Wednesday, Dec. 2, 2009. It will be avai...iocast accessible via the investor relations secti...
(Date:11/6/2009)...ed today from Jackson Healthcare reports that the ...they have less control over the way they practice ... Alpharetta, GA (Vocus) November 6,...lthcare reports that the majority of physicians s...ver the way they practice medicine than they did f...
Breaking Medicine News(10 mins):Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2Health News:VA Summit Frames Plan to End Veteran Homelessness 2Health News:AARP Calls On Idaho's U.S. Reps To Back House Health Care Reform Bill 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4
...t the Dana-Farber Cancer Institute have identified..., in monkey cells. Humans have a similar protein, ...ay the researchers whose work //is published in th...). "Identification of this HIV-blocking fact...
... recent findings researchers say the risks and ben... to be re-evaluated.// Researchers from Sweden stu...erapy before 18 months of age. Participants had th...study showed boys who received increasing doses of...
...dy shows that measuring ones blood pressure at hom... slightly lower costs.// Researchers compared sel...octors’ office measurements of blood pressure for ...ns’ offices were included for the study. All of th...
...say a new treatment can now help chronic chest pai...ine was taken // with other antianginal medication...of patients with symptoms of chronic angina. ...ive a placebo or one or two doses of ranolazine. P...
...ation is a non-surgical technique used to eliminat...bnormal heartbeats. // Researchers now say that co...al fibrillation a type of irregular heart rhythm ...ho were undergoing catheter ablation for atrial fi...
...suggests techniques used to clear arteries blocked...artery to prevent stroke.// Three years after ...s show angioplasty and stenting are as effective a...en, the artery is widened by inflating a balloon a...
Other Medicine News:
(Date:11/6/2009)... Ardea Biosciences, Inc. ...on the development of small-molecule therapeutics ...deficiency virus (HIV), today reported recent acco...arter and nine months ended September 30, 2009. ,...20091104/ARDEALOGO ) ,, "Since our last quarter...
(Date:11/6/2009)...RNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bu...an Atlanta-based, biopharmaceutical company develo...Human Immunodeficiency Virus) and other infectious...nancial results and provided an operational update... Executive Officer commented, "We are pleased with...
(Date:11/6/2009)...r 6 , - Trial Will Compar...,Treatment of Multi-Resistant Staphylococcus Aureu...ty pharmaceutical company focused on the discovery...overcome the significant global,problem of microbi...ced oral,antibacterial NXL103 (flopristin/linopris...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Two Thirds of Americans Concerned About H1N1 But Most Dont Change Hygiene Habits 56016 1Two Thirds of Americans Concerned About H1N1 But Most Dont Change Hygiene Habits 56016 2Two Thirds of Americans Concerned About H1N1 But Most Dont Change Hygiene Habits 56016 3ReBuilder Medical Technologies Inc Announces Unique Arthritic Pain Accessory 56012 1ReBuilder Medical Technologies Inc Announces Unique Arthritic Pain Accessory 56012 2JDRF award supports study of potential target for blocking type 1 diabetes 56008 1JDRF award supports study of potential target for blocking type 1 diabetes 56008 2
... for Aesthetic Plastic,Surgery,s Annual Meeting, ...rgical and nonsurgical cosmetic enhancement are be...ations really deliver what they promise? Are,the r...the benefit of,little or no downtime, comparable t...ies safe and cost-effective for patients? These ar...
...SHPGY), the global specialty biopharmaceutical com...entific data on its Attention Deficit,Hyperactivit...esylate,methylphenidate transdermal system and the... review, guanfacine extended release, at the Ameri...o be held May 3rd to 8th in,Washington, D.C., "Sh...
Other Medicine Technology:Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures 2Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures 3Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 2Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 3Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting 4
...e new line of Myoquick systemplus Multi-channels E...xcellence of Micromed in the neurophysiology field...the company. Multi-channel EP unit adopt the 32 ch... Stimulation systems of the ISA 100x EP family hea...
Burton Dura-test Motorized Instrument Table
Burton 1200 Chair-exchanger
...marvel of engineering and innovative design, the B...sion, unparalleled quality and masterful workmansh...hthalmic industry a truly innovative concept, but ...to quality construction and stringent testing, we ...
Medicine Products: